AstraZeneca COVID-19 vaccine 76% effective in updated U.S. trial results
The updated 76% efficacy rate compares with rates of about 95% for vaccines from Pfizer/BioNTech and Moderna.
Full Article
AstraZeneca COVID-19 vaccine 76% effective in updated U.S. trial results
Hindu
0 shares
1 views
You might like
Related news coverage
When Will Kids Have A Covid-19 Vaccine?
Newsy
Watch VideoResearchers test vaccines in adults first, then typically move down the age brackets and that includes Moderna and..
Advertisement
More coverage
AstraZeneca revises down its vaccine efficacy in a huge US trial, from 79% to 76%, following concerns from Fauci and other experts that the results were outdated
Business Insider
AstraZeneca said Thursday in updated results that its COVID-19 vaccine was still 100% effective at preventing severe disease and..
-
AstraZeneca updates report, insists COVID vaccine highly effective
CBS News
-
AstraZeneca COVID-19 vaccine 76% effective in updated US trial results
Indian Express
-
AstraZeneca Covid-19 vaccine 76% effective in updated US trial results
IndiaTimes
-
COVID-19 vaccine from AstraZeneca-Oxford slightly less effective than first touted: 76% rather than 79% against disease, updated data shows
Upworthy